<?xml version="1.0" encoding="UTF-8"?>
<xml>
<records>
<record>
  <ref-type name="Journal Article">17</ref-type>
  <contributors>
    <authors>
      <author>Dormann, Dorothee</author>
      <author>Madl, Tobias</author>
      <author>Valori, Chiara F</author>
      <author>Bentmann, Eva</author>
      <author>Tahirovic, Sabina</author>
      <author>Abou-Ajram, Claudia</author>
      <author>Kremmer, Elisabeth</author>
      <author>Ansorge, Olaf</author>
      <author>Mackenzie, Ian R A</author>
      <author>Neumann, Manuela</author>
      <author>Haass, Christian</author>
    </authors>
    <subsidiary-authors>
      <author>AG Neumann</author>
    </subsidiary-authors>
  </contributors>
  <titles>
    <title>Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS.</title>
    <secondary-title>The EMBO journal</secondary-title>
  </titles>
  <periodical>
    <full-title>The EMBO journal</full-title>
  </periodical>
  <publisher>Wiley</publisher>
  <pub-location>Hoboken, NJ [u.a.]</pub-location>
  <isbn>0261-4189</isbn>
  <electronic-resource-num>10.1038/emboj.2012.261</electronic-resource-num>
  <language>English</language>
  <pages>4258-4275</pages>
  <number>22</number>
  <volume>31</volume>
  <abstract>Fused in sarcoma (FUS) is a nuclear protein that carries a proline-tyrosine nuclear localization signal (PY-NLS) and is imported into the nucleus via Transportin (TRN). Defects in nuclear import of FUS have been implicated in neurodegeneration, since mutations in the PY-NLS of FUS cause amyotrophic lateral sclerosis (ALS). Moreover, FUS is deposited in the cytosol in a subset of frontotemporal lobar degeneration (FTLD) patients. Here, we show that arginine methylation modulates nuclear import of FUS via a novel TRN-binding epitope. Chemical or genetic inhibition of arginine methylation restores TRN-mediated nuclear import of ALS-associated FUS mutants. The unmethylated arginine-glycine-glycine domain preceding the PY-NLS interacts with TRN and arginine methylation in this domain reduces TRN binding. Inclusions in ALS-FUS patients contain methylated FUS, while inclusions in FTLD-FUS patients are not methylated. Together with recent findings that FUS co-aggregates with two related proteins of the FET family and TRN in FTLD-FUS but not in ALS-FUS, our study provides evidence that these two diseases may be initiated by distinct pathomechanisms and implicates alterations in arginine methylation in pathogenesis.</abstract>
  <notes/>
  <label>PUB:(DE-HGF)16, ; 0, ; </label>
  <keywords>
    <keyword>Active Transport, Cell Nucleus</keyword>
    <keyword>Amino Acid Sequence</keyword>
    <keyword>Amyotrophic Lateral Sclerosis: genetics</keyword>
    <keyword>Amyotrophic Lateral Sclerosis: metabolism</keyword>
    <keyword>Arginine: metabolism</keyword>
    <keyword>Cell Nucleus: metabolism</keyword>
    <keyword>Frontotemporal Lobar Degeneration: metabolism</keyword>
    <keyword>Gene Silencing</keyword>
    <keyword>HeLa Cells</keyword>
    <keyword>Humans</keyword>
    <keyword>Karyopherins: genetics</keyword>
    <keyword>Karyopherins: metabolism</keyword>
    <keyword>Methylation</keyword>
    <keyword>Molecular Sequence Data</keyword>
    <keyword>Nuclear Localization Signals: metabolism</keyword>
    <keyword>Proline: metabolism</keyword>
    <keyword>Protein Binding</keyword>
    <keyword>Protein-Arginine N-Methyltransferases: genetics</keyword>
    <keyword>Protein-Arginine N-Methyltransferases: metabolism</keyword>
    <keyword>RNA-Binding Protein FUS: genetics</keyword>
    <keyword>RNA-Binding Protein FUS: metabolism</keyword>
    <keyword>Repressor Proteins: genetics</keyword>
    <keyword>Repressor Proteins: metabolism</keyword>
    <keyword>Signal Transduction</keyword>
    <keyword>Tyrosine: metabolism</keyword>
    <keyword>Karyopherins</keyword>
    <keyword>Nuclear Localization Signals</keyword>
    <keyword>RNA-Binding Protein FUS</keyword>
    <keyword>Repressor Proteins</keyword>
    <keyword>Tyrosine</keyword>
    <keyword>Arginine</keyword>
    <keyword>Proline</keyword>
    <keyword>PRMT1 protein, human</keyword>
    <keyword>Protein-Arginine N-Methyltransferases</keyword>
  </keywords>
  <accession-num/>
  <work-type>Journal Article</work-type>
  <dates>
    <pub-dates>
      <year>2012</year>
    </pub-dates>
  </dates>
  <accession-num>DZNE-2020-03019</accession-num>
  <year>2012</year>
  <custom2>pmc:PMC3501225</custom2>
  <custom6>pmid:22968170</custom6>
  <urls>
    <related-urls>
      <url>https://pub.dzne.de/record/136697</url>
      <url>https://doi.org/10.1038/emboj.2012.261</url>
    </related-urls>
  </urls>
</record>

</records>
</xml>